Oncology in the genomics era
Cancer treatment options are rapidly evolving. Rapid advancement in cancer genomics and technology is leading to increasing availability of targeted therapies. Coupled with genomic testing, these new therapeutic options present unprecedented opportunities to more effectively tailor clinical treatment to each patient.
While cancer genomics offers much promise, this science is also making the practice of oncology more complex and challenging. How can you keep up-to-date on the massive amount of emerging research data associated with every cancer you treat? How can you readily obtain, interpret and integrate genomic data about your patients’ cancers into informed treatment recommendations?
Foundation Medicine’s solution
Foundation Medicine has developed FoundationOneTM, a comprehensive cancer genomic test that analyzes routine clinical specimens for somatic alterations in relevant cancer-related genes. Our test provides individualized, potentially actionable information in a coordinated and easily accessible way. It serves as a tool to assist physicians seeking appropriate treatment options that are specific and unique to each patient.
In this section
- Impact of cancer genomics on advances in cancer treatment
- Promises and challenges of personalized medicine for improving cancer treatment and care
- Information about Foundation Medicine’s comprehensive cancer genomics test
